Suppr超能文献

肼屈嗪对血管平滑肌的作用机制。

Mechanism of action of hydralazine on vascular smooth muscle.

作者信息

Jacobs M

出版信息

Biochem Pharmacol. 1984 Sep 15;33(18):2915-9. doi: 10.1016/0006-2952(84)90216-8.

Abstract

Myofibrils prepared from bovine carotid arteries were used to investigate the hypotensive action of hydralazine. These myofibrils contained an ATPase and Protein Kinase which was half-maximally activated by 1 microM Ca2+. Hydralazine inhibited Ca2+ dependent ATPase and phosphorylation. Half maximal inhibition occurred at 2 X 10(-5) M hydralazine. This inhibition was accounted for by a specific reduction in the phosphorylation of a protein which migrated with the myosin P-light chains (Mr, 20,000). Phosphorylation of the latter protein is generally thought to be obligatory for muscle contraction. Thus an inhibition of this phosphorylation by hydralazine in vivo is likely to contribute to the hypotensive action of the drug.

摘要

从牛颈动脉制备的肌原纤维用于研究肼屈嗪的降压作用。这些肌原纤维含有一种ATP酶和蛋白激酶,该蛋白激酶在1微摩尔钙离子浓度下被半最大激活。肼屈嗪抑制钙离子依赖性ATP酶和磷酸化作用。在2×10⁻⁵M肼屈嗪浓度下出现半最大抑制。这种抑制作用是由于与肌球蛋白P轻链(分子量20,000)一起迁移的一种蛋白质的磷酸化特异性降低所致。一般认为后者蛋白质的磷酸化是肌肉收缩所必需的。因此,肼屈嗪在体内对这种磷酸化的抑制作用可能有助于该药物的降压作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验